Arecor Therapeutics (AREC)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 76.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 199.00p
  • 52 Week Low: 66.00p
  • Currency: UK Pounds
  • Shares Issued: 37.76m
  • Volume: 413
  • Market Cap: £28.88m
  • Beta: 0.09

Largest Trades

Time Price Volume Value Buy/Sell Type
21-Nov-2024 11:00 73.50p 392 £288 Sell
21-Nov-2024 11:00 73.50p 392 £288 Sell TK
21-Nov-2024 09:00 73.50p 20 £15 Sell
21-Nov-2024 09:00 73.50p 20 £15 Sell TK
21-Nov-2024 08:15 78.00p 1 £1 Buy O

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AREC Market Data

Currency UK Pounds
Share Price 76.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 199.00p
52 Week Low 66.00p
Volume 413
Shares Issued 37.76m
Market Cap £28.88m
Beta 0.09

AREC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average53.6% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
87.11% below the market average87.11% below the market average87.11% below the market average87.11% below the market average87.11% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Income Not Available
Growth
59.12% above the market average59.12% above the market average59.12% above the market average59.12% above the market average59.12% above the market average
64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average64.71% above the sector average

AREC Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
11:00 392 @ 73.50p
11:00 392 @ 73.50p
09:00 20 @ 73.50p
09:00 20 @ 73.50p
08:15 1 @ 78.00p

AREC Key Personnel

CEO Sarah Jennifer Howell
CFO David Ellam

Top of Page